340
Participants
Start Date
December 18, 2003
Primary Completion Date
July 5, 2018
Study Completion Date
July 20, 2018
Reduced Intensity Conditioning Stem Cell Transplantation
"One of the following conditioning regimens:~1. Busulphan (orally or IV), fludarabine~2. Fludarabine, carmustine, melfalan~3. Cyclophosphamide, fludarabine"
Royal Prince Alfred Hospital, Camperdown
Austalasian Leukaemia &Lymphoma Group Limited, East Melbourne
Royal Adelaide Hospital, Adelaide
Wellington Hospital, Wellington
Turku University Hospital, Turku
University Hospital of Patras, Pátrai
Department of Hematology, Sahlgrenska University Hospital, Gothenburg
Tartu University Hospital, Tartu
Dept of Hematology, University Hospital, Freiburg im Breisgau
Cancer Care Manitoba, Winnipeg
McMaster Site Ward 3Z, Hamilton Health Sciences, Hamilton
Hematology, Ottawa Hospital, Ottawa
Hématologie, Maisonneuve-Rosemont Hospital, Montreal
Hematology, Royal Victoria Hospital, Montreal
Hématologie, Hospital CHA Enfant-Jésus, Québec
L'Hôtel Dieu de Quebec, Québec
Christchurch Hospital, Christchurch
Sunderby Hospital, Luleå
Skåne University Hospital Lund, Lund
University Hospital Örebro, Örebro
Karolinska University Hospital Huddinge, Stockholm
Karolinska University Hospital Solna, Stockholm
Uppsala Akademiska Hospital, Uppsala
Saskatoon Cancer Centre, Saskatoon
Section of Hematology, National Hospital, Oslo
The Canadian Blood and Marrow Transplant Group
NETWORK
Australasian Leukaemia and Lymphoma Group
OTHER
Vastra Gotaland Region
OTHER_GOV